Friday, January 21, 2011

Our Solution

Part 1: iPulse

iPulse is a heart rate monitor that can be worn as a watch at your wrist. It is able to receive information such as heart rates via Bluetooth. This function is wireless and thus reduces the hassle to untangle wires or pose as an electrical hazard.

It consists of 2 attachments; firstly it is the “Chest Pad” and secondly it has another attachment that has a syringe containing the suppressing formula.

The Chest Pad has to be worn on the centre of the chest as it is nearer to the heart. It measures the heart rate per seconds and the information can be sent over to the iPulse via Bluetooth.

The syringe is attached to a wire that can be connected to the iPulse through a jack and releases the formula once the chest pad has detected that the user has gotten a heart attack. This formula must be released within the golden 5 minutes during the start of the attack.

In the formula, it contains the NanoCrab which is the second part of our solution.

Part 2: Nanocrab

What is Nanocrab?

It is a nanoparticle that has a crab-like structure and it flows in the bloodstream of the artery.

Its Structure

Its claw structure contains L-lysine in order to detect a plaque caused by atherosclerosis. L-lysine actually bonds to the plaque and prodcues carnitine which converts fatty acids to energy. Due to excessive fatty materials in the patient, it is important that we remove the excess or even change the excess to something more essential such as energy. Thus at the same time, it will ‘scrape’ the plaque off slowly. These waste products will be removed via usual metabolic processes.

Disadvantages of its structure

However, what we are afraid is that this Nanocrab may cause abrasion against the walls of the arteries due to its crab-like structures. Overtime, abrasion may even lead to damaged blood vessels.

How will damaged blood vessels be healed then?

When blood vessels are damaged, it will lead to blood clotting. Clotting of blood will be done at the site of damage.

No comments:

Post a Comment